Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 2 Published - 14:00 UTC    08:00 EST    01-January-2001      
Issue 1 Next Update - 14:00 UTC 08:00 EST    02-January-2001      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Back To Vidyya FDA Accepts FluMist(TM) Biologics License Application (BLA) For Review

FluMist Is An Investigational Intranasal Influenza Vaccine

Aviron has announced that the U.S. Food and Drug Administration (FDA) accepted for review a Biologics License Application (BLA) for FluMist(TM), an investigational intranasal influenza vaccine.

On October 31, 2000, Aviron submitted a BLA to the FDA seeking U.S. licensure of FluMist(TM) to prevent influenza in healthy children and healthy adults. Friday's decision by the FDA to accept the submission for review was the next step in the regulatory process. If approved, FluMist(TM) would be the first flu vaccine delivered as a nasal mist to be commercially available in the US.

The BLA acceptance triggers a $15.5 million payment to Aviron from American Home Products Corporation as part of an ongoing global collaboration agreement for the development and marketing of FluMist(TM).

Annual influenza epidemics in the United States typically affect 10 to 20 percent of the general population and cause approximately 20,000 deaths. FluMist(TM), which is delivered as a nasal mist, could be an important new way to protect people from the flu. FluMist(TM) may be particularly significant for children, who suffer high influenza attack rates and are thought to be important in the spread of influenza.

Aviron is a biopharmaceutical company based in Mountain View, California, focused on the prevention of disease through innovative vaccine technology. For more information, visit Aviron Influenza Overview - Recent Results.


Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 
Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.